Clinical value of antibodies to lysobisphosphatidic acid in patients with primary antiphospholipid sindrome

To assess the clinical value of anti-lysobisphosphatidic acid (anti-LBPA) antibodies in patients with primary antiphospholipid syndrome (APS), the sera of 140 primary APS patients were tested and compared with those of 70 control subjects affected with rheumatic systemic diseases (n. 24) or autoimmu...

Full description

Bibliographic Details
Main Authors: S. Giunco, S. Cuffaro, E. Salvan, A. Cavazzana, A. Bontadi, A. Ruffatti, S. Olivieri, L. Punzi
Format: Article
Language:English
Published: PAGEPress Publications 2011-06-01
Series:Reumatismo
Online Access:http://www.reumatismo.org/index.php/reuma/article/view/471

Similar Items